TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 21 filers reported holding TALIS BIOMEDICAL CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $751 | -2.0% | 1,564 | 0.0% | 0.00% | – |
| Q1 2023 | $766 | – | 1,564 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 1,564 | -21.8% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -77.8% | 2,000 | -7.0% | 0.00% | – |
| Q4 2021 | $9,000 | -30.8% | 2,150 | 0.0% | 0.00% | – |
| Q3 2021 | $13,000 | 0.0% | 2,150 | +87.0% | 0.00% | – |
| Q2 2021 | $13,000 | -13.3% | 1,150 | 0.0% | 0.00% | – |
| Q1 2021 | $15,000 | – | 1,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|